Abstract
Capecitabine plus oxaliplatin combination (XELOX) is the first-line treatment in metastatic colorectal cancer. Here we report a case of acute, severe but substantially reversible, neuromuscular and cardiac toxicity following XELOX chemotherapy. Muscle biopsy findings were consistent with a toxic myopathy with necrotizing features and vacuolar changes; COX-negative fibers were also present. The time course could support a main role for capecitabine, which may have some neurotoxic effects (more frequently central), but a detrimental interaction between the two drugs cannot be ruled out and further studies are needed.
Copyright © 2012 Elsevier B.V. All rights reserved.
MeSH terms
-
Adenocarcinoma / drug therapy
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Capecitabine
-
Cardiomyopathies / chemically induced*
-
Cardiomyopathies / diagnosis
-
Cardiomyopathies / pathology
-
Colorectal Neoplasms / drug therapy
-
Deoxycytidine / adverse effects
-
Deoxycytidine / analogs & derivatives*
-
Deoxycytidine / therapeutic use
-
Female
-
Fluorouracil / adverse effects
-
Fluorouracil / analogs & derivatives*
-
Fluorouracil / therapeutic use
-
Humans
-
Middle Aged
-
Neuromuscular Diseases / chemically induced*
-
Neuromuscular Diseases / diagnosis
-
Neuromuscular Diseases / pathology
-
Organoplatinum Compounds / adverse effects*
-
Organoplatinum Compounds / therapeutic use
-
Oxaliplatin
Substances
-
Organoplatinum Compounds
-
Oxaliplatin
-
Deoxycytidine
-
Capecitabine
-
Fluorouracil